Sleep Disorders

In a small group of patients with major depressive disorder and symptoms of insomnia, treatment with the antidepressant vortioxetine significantly improved depression and sleep issues.

Articles

Use the links below to see all of our coverage of sessions, speakers, and posters at Psych Congress 2018.

The experimental drug solriamfetol appears to keep sleepy patients with narcolepsy or obstructive sleep apnea (OSA) awake and alert, according to an industry-sponsored trial.

People with insomnia who receive a digitized version of cognitive behavioral therapy as part of their treatment may find more symptom relief than those who only receive tips to improve their sleep routines, a recent experiment suggests.

In a small group of patients with major depressive disorder and symptoms of insomnia, treatment with the antidepressant vortioxetine significantly improved depression and sleep issues.

ORLANDO, Fla.—Sodium oxybate demonstrated long-term efficacy in the treatment of narcolepsy in pediatric patients, with a safety profile consistent with that seen in adults, according to study results presented at Psych Congress 2018.

Pages

Blogs

How aggressive are you in treating insomnia in your patients, and how do you choose which agent to use?

Sleep apnea is one of the most common and most important sleep disorders in psychiatry. Clinicians should understand when and why to screen for this disorder.

My interest in sleep is clinically selfish: Knowing a little about sleep makes me a better psychiatrist.

Pages

Video

Psych Congress Steering Committee member Saundra Jain, MA, PsyD, LPC discusses the role of sleep in mental wellness, recommended sleep strategies, and increasing patient adherence.

Sleep expert Karl Doghramji, MD, and Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discuss exciting developments in sleep medicine.

Karl Doghramji, MD, Professor at the Sleep Disorders Center at Jefferson University in Philadelpha, Pennsylvania, joins Rakesh Jain, MD, MPH, to talk about how clinicians can benefit from considering the mechanistic receptor profiles of interventions for sleep disorders. To read a transcript of the video conversation, click here

Pages

Tools